Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-15 Protein (AA 49-162) (His tag)

IL15 Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant >95 % (SDS-PAGE)
N° du produit ABIN7278701
  • Antigène Voir toutes IL-15 (IL15) Protéines
    IL-15 (IL15) (Interleukin 15 (IL15))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 49-162
    Origine
    • 22
    • 8
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Source
    • 35
    • 10
    • 10
    • 2
    • 2
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette IL-15 protéine est marqué à la His tag.
    Fonction
    IL-15 (human) (rec.) (His)
    Specificité
    The extracellular domain of human IL-15 (aa 49-162) is fused to a His-tag.
    Attributs du produit
    Protein. The extracellular domain of human IL-15 (aa 49-162) is fused to a His-tag. Source: E. coli. Endotoxin content: <0.1EU/μg protein (LAL test, Lonza). Lyophilized from 0.2μm-filtered solution in PBS. Purity: >95 % (SDS-PAGE). Interleukin-15 (IL-15) has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. IL-15 participates in the development of important immune antitumor mechanisms. It activates CD8(+) T cells, natural killer (NK) cells, NK T cells, and can promote the formation of antitumor antibodies. IL-15 can also protect T effector cells from the action of T regulatory cells and reverse tolerance to tumor-associated antigens. In pre-clinical studies IL-15 has been found to demonstrate potentiated antitumor effects following pre-association with IL-15Ralpha, or when used in combination with chemotherapy, adoptive therapy, monoclonal antibodies, and tumor vaccines.
    Pureté
    >95 % (SDS-PAGE)
    niveau d'endotoxine
    <0.1EU/μg protein (LAL test, Lonza).
    Biological Activity Comment
    Measured by its ability to stimulate the proliferation of mouse CTLL-2 cells. The ED50 for this effect is typically 0.5ng/mL, corresponding to a specific activity of 2x 106 units/mg
    Top Product
    Discover our top product IL15 Protéine
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    Lot specific
    Buffer
    Lyophilized from 0.2μm-filtered solution in PBS.
    Conseil sur la manipulation
    Avoid freeze/thaw cycles. PBS containing at least 0.1 % BSA should be used for further dilutions.
    Stock
    4 °C,-20 °C
    Stockage commentaire

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 1 year after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.

  • Antigène
    IL-15 (IL15) (Interleukin 15 (IL15))
    Autre désignation
    IL-15 (IL15 Produits)
    Synonymes
    IL15 Protein, AI503618 Protein, IL-15 Protein, interleukin 15 Protein, IL15 Protein, Il15 Protein
    Sujet

    Alternate Names/Synonyms: Interleukin-15

    Product Description: Interleukin-15 (IL-15) has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. IL-15 participates in the development of important immune antitumor mechanisms. It activates CD8(+) T cells, natural killer (NK) cells, NK T cells, and can promote the formation of antitumor antibodies. IL-15 can also protect T effector cells from the action of T regulatory cells and reverse tolerance to tumor-associated antigens. In pre-clinical studies IL-15 has been found to demonstrate potentiated antitumor effects following pre-association with IL-15Ralpha, or when used in combination with chemotherapy, adoptive therapy, monoclonal antibodies, and tumor vaccines.

    Poids moléculaire
    ~14kDa (SDS-PAGE)
    NCBI Accession
    NP_751914
    Pathways
    Signalistation JAK/STAT, Glycosaminoglycan Metabolic Process
Vous êtes ici:
Support technique